Patents by Inventor Ariel Gispan

Ariel Gispan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OMNI-103 CRISPR NUCLEASE
    Publication number: 20250051741
    Abstract: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence of SEQ ID NO: 1 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
    Type: Application
    Filed: March 22, 2024
    Publication date: February 13, 2025
    Applicant: EmendoBio Inc.
    Inventors: Lior Izhar, Nadav Marbach Bar, Liat Rockah, Nurit Meron, Ophir Adiv Tal, Ariel Gispan, Idit Buch, Nir Hecht
  • OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376,
    Publication number: 20250011741
    Abstract: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence selected from the group consisting of SEQ ID NOs: 1-108 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
    Type: Application
    Filed: November 17, 2022
    Publication date: January 9, 2025
    Applicant: EMENDOBIO INC
    Inventors: Lior IZHAR, Nadav MARDACH BAR, Liat ROCKAH, Nir HECHT, Sigal COHEN, Nurit MERON, Ophir ADIV, Ariel GISPAN, Idit BUCH
  • NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES
    Publication number: 20250011740
    Abstract: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence selected from the group consisting of SEQ ID NOs: 1-88 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
    Type: Application
    Filed: April 21, 2022
    Publication date: January 9, 2025
    Applicant: EmendoBio Inc.
    Inventors: Lior Izhar, Nadav Marbach Bar, Liat Rockah, Nurit Meron, Ophir Adiv Tal, Ariel Gispan, Idit Buch
  • OMNI 90-99, 101, 104-110, 114, 116, 118-123, 125, 126, 128, 129, and 131-138 CRISPR NUCLEASE
    Publication number: 20240425885
    Abstract: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence selected from the group consisting of SEQ ID NOs: 1-11 and 13-39 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
    Type: Application
    Filed: February 7, 2022
    Publication date: December 26, 2024
    Applicant: EmendoBio Inc.
    Inventors: Lior Izhar, Nadav Marbach Bar, Liat Rockah, Nurit Meron, Ophir Adiv Tal, Ariel Gispan, Idit Buch
  • NOVEL OMNI 115, 124, 127, 144-149, 159, 218, 237, 248, 251-253 AND 259 CRISPR NUCLEASES
    Publication number: 20240376453
    Abstract: The present invention disclosed herein are compositions that may be utilized for modifying genomic DNA sequences. comprising a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence selected from the group consisting of SEQ ID NOs: 1-17 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
    Type: Application
    Filed: August 12, 2022
    Publication date: November 14, 2024
    Applicant: EmendoBio Inc.
    Inventors: Lior IZHAR, Nadav MARBACH BAR, Liat ROCKAH, Nurit MERON, Ophir ADIV TAL, Ariel GISPAN, Idit BUCH
  • OMNI-103 CRISPR nuclease
    Patent number: 12091688
    Abstract: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence of SEQ ID NO: 1 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
    Type: Grant
    Filed: February 7, 2022
    Date of Patent: September 17, 2024
    Assignee: EmendoBio Inc.
    Inventors: Lior Izhar, Nadav Marbach Bar, Liat Rockah, Nurit Meron, Ophir Adiv Tal, Ariel Gispan, Idit Buch, Nir Hecht
  • OMNI-103 CRISPR NUCLEASE
    Publication number: 20230303989
    Abstract: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence of SEQ ID NO: 1 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
    Type: Application
    Filed: February 7, 2022
    Publication date: September 28, 2023
    Applicant: EmendoBio Inc.
    Inventors: Lior Izhar, Nadav Marbach Bar, Liat Rockah, Nurit Meron, Ophir Adiv Tal, Ariel Gispan, Idit Buch, Nir Hecht